Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 4534470)

Published in Mol Med on April 15, 2015

Authors

Ji Yang1, Qiao Li2, Xue Yang3,4, Ming Li1

Author Affiliations

1: Department of Dermatology, Zhongshan Hospital, Fudan University, Shanghai, China.
2: Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
3: Division of Rheumatology, Huashan Hospital, Fudan University, Shanghai, China.
4: Institute of Rheumatology, Immunology and Allergy, Fudan University, Shanghai, China.

Articles cited by this

Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med (2003) 10.82

Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol (2008) 6.76

IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol (2008) 6.41

IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med (2009) 5.05

Retracted Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol (2009) 3.84

IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc Natl Acad Sci U S A (2009) 3.31

Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum (2009) 2.43

B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J Exp Med (2010) 2.42

A brief history of IL-9. J Immunol (2011) 2.27

Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J Exp Med (1992) 2.27

Th9 and allergic disease. Immunology (2009) 1.97

Th9 cells: differentiation and disease. Immunol Rev (2013) 1.61

Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP. Immunity (2013) 1.43

Th9 cells, new players in adaptive immunity. Trends Immunol (2013) 1.28

Interleukin-17-producing T cells in lupus. Curr Opin Rheumatol (2010) 1.19

Human CD4 memory T cells can become CD4+IL-9+ T cells. PLoS One (2010) 1.12

Recovery of the immune balance between Th17 and regulatory T cells as a treatment for systemic lupus erythematosus. Rheumatology (Oxford) (2011) 1.11

Interleukin-9 as a T helper type 17 cytokine. Immunology (2010) 1.01

Tumor-specific IL-9-producing CD8+ Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers. Proc Natl Acad Sci U S A (2014) 1.00

Increased interleukin‑9 and CD4+IL-9+ T cells in patients with systemic lupus erythematosus. Mol Med Rep (2013) 1.00

Serum interleukin 9 levels are increased in patients with systemic sclerosis: association with lower frequency and severity of pulmonary fibrosis. J Rheumatol (2011) 0.94

Possible pathogenic role of T helper type 9 cells and interleukin (IL)-9 in atopic dermatitis. Clin Exp Immunol (2014) 0.94

Neutralization of IL-17 ameliorates uveitis but damages photoreceptors in a murine model of spondyloarthritis. Arthritis Res Ther (2012) 0.93

Effects of interleukin-9 blockade on chronic airway inflammation in murine asthma models. Allergy Asthma Immunol Res (2013) 0.93

Expression of IL-9 receptor alpha chain on human germinal center B cells modulates IgE secretion. J Allergy Clin Immunol (2007) 0.93

IL-9-producing invariant NKT cells protect against DSS-induced colitis in an IL-4-dependent manner. Mucosal Immunol (2012) 0.85

IL-9 regulates allergen-specific Th1 responses in allergic contact dermatitis. J Invest Dermatol (2014) 0.85

Potential roles of IL-9 in the pathogenesis of systemic lupus erythematosus. Am J Clin Exp Immunol (2012) 0.83